Canadian Journal of Cardiology

Article	Citations
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults	384
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation	317
Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children	312
Missing Data in Clinical Research: A Tutorial on Multiple Imputation	273
Opening the Black Box: The Promise and Limitations of Explainable Machine Learning in Cardiology	196
Left Bundle Branch Pacing for Cardiac Resynchronization Therapy: Nonrandomized On-Treatment Comparison With His Bundle Pacing and Biventricular Pacing	171
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction	165
Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited	157
Oxidative Stress: A Unifying Paradigm in Hypertension	135
Inflammation in Hypertension	130
Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective	126
Echocardiographic Findings in Patients With COVID-19 Pneumonia	123
Management and Treatment of COVID-19: The Chinese Experience	123
Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries	104
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society	88
The Importance of Gender to Understand Sex Differences in Cardiovascular Disease	82
Reduced Physical Activity During COVID-19 Pandemic in Children With Congenital Heart Disease	77
Characteristic Electrocardiographic Manifestations in Patients With COVID-19	77
Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials	67
Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction?	66
Cardiac Rehabilitation During the COVID-19 Era: Guidance on Implementing Virtual Care	66
The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis	59
Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS/CHRS, ESC, and AHA/ACC/HRS Guidelines	53
Worsening Hypertension Awareness, Treatment, and Control Rates in Canadian Women Between 2007 and 2017	51
COVID-19: A Time for Alternate Models in Cardiac Rehabilitation to Take Centre Stage	51

Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance	51
Reduced Rate of Hospital Presentations for Heart Failure During the COVID-19 Pandemic in Toronto, Canada	50
Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology	49
COVID-19–Myocarditis and Return to Play: Reflections and Recommendations From a Canadian Working Group	48
Simplifying Physiological Left Bundle Branch Area Pacing Using a New Nine-Partition Method	47
Effectiveness of Mobile Health Technology Interventions for Patients With Heart Failure: Systematic Review and Meta-analysis	46
Cardiac Surgery in Canada During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons	46
WHO HEARTS: A Global Program to Reduce Cardiovascular Disease Burden: Experience Implementing in the Americas and Opportunities in Canada	45
Usefulness of Machine Learning-Based Detection and Classification of Cardiac Arrhythmias With 12-Lead Electrocardiograms	45
How Structure, Mechanics, and Function of the Vasculature Contribute to Blood Pressure Elevation in Hypertension	45
Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers	42
Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes	41
Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19	41
Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease	41
Implications of the COVID-19 Pandemic for Cardiovascular Disease and Risk-Factor Management	37
Childhood Obesity and Cardiovascular Disease Risk: Working Toward Solutions	37
The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy	35
Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?	34
Physical Functioning, Mental Health, and Quality of Life in Different Congenital Heart Defects: Comparative Analysis in 3538 Patients From 15 Countries	34
Calcium-Sensing Receptor on Neutrophil Promotes Myocardial Apoptosis and Fibrosis After Acute Myocardial Infarction via NLRP3 Inflammasome Activation	33
Physical Activity Promotion in Pediatric Congenital Heart Disease: Are We Running Late?	32
Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics	32
Late STEMI and NSTEMI Patients’ Emergency Calling in COVID-19 Outbreak	30
Machine Learning Compared With Conventional Statistical Models for Predicting Myocardial Infarction Readmission and Mortality: A Systematic Review	30
2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients With Structural Heart Disease	30
Predicting Myocardial Injury and Other Cardiac Complications After Elective Noncardiac Surgery with the Revised Cardiac Risk Index: The VISION Study	29
Hypertension Canada’s 2020 Evidence Review and Guidelines for the Management of Resistant Hypertension	29
Extreme Heat and Cardiovascular Health: What a Cardiovascular Health Professional Should Know	29
Canadian Cardiovascular Society 2022 Guidelines for Cardiovascular Interventions in Adults With Congenital Heart Disease	29
Digital Technology Application for Improved Responses to Health Care Challenges: Lessons Learned From COVID-19	28
An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience Under Real-World Suboptimal Conditions	28
A Novel Approach to Medical Management of Heart Failure With Reduced Ejection Fraction	28
Recent Progress Toward Clinical Translation of Tissue-Engineered Heart Valves	27
Canadian Cardiovascular Society/Canadian Thoracic Society Position Statement on Pulmonary Hypertension	27
The Metaverse in Cardiovascular Medicine: Applications, Challenges, and the Role of Non-Fungible Tokens	27
The Novel Desmin Variant p.Leu115Ile Is Associated With a Unique Form of Biventricular Arrhythmogenic Cardiomyopathy	27
Links Between Child and Adolescent Psychiatric Disorders and Cardiovascular Risk	27
Genomics of Blood Pressure and Hypertension: Extending the Mosaic Theory Toward Stratification	27
Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 2020 SARS-CoV-2 Pandemic	26
Prenatal Diagnosis of Transposition of the Great Arteries Reduces Postnatal Mortality: A Population-Based Study	26
Impact of Flow Dynamics on Device-Related Thrombosis After Left Atrial Appendage Occlusion	26
Sports-Related Sudden Cardiac Arrest in Germany	25
Prediction of Sudden Cardiac Arrest in the General Population: Review of Traditional and Emerging Risk Factors	25
Sex and Race Differences in the Pathophysiology, Diagnosis, Treatment, and Outcomes of Valvular Heart Diseases	25
Canadian Cardiovascular Society Clinical Practice Update on the Assessment and Management of Syncope	25
The Impact of the COVID-19 Pandemic on Cardiac Procedure Wait List Mortality in Ontario, Canada	24
The 30-Year Outcomes of Tetralogy of Fallot According to Native Anatomy and Genetic Conditions	24
Canadian Cardiovascular Society: Clinical Practice Update on Cardiovascular Management of the Pregnant Patient	24
Risk Factors for Mortality and Ventricular Tachycardia in Patients With Repaired Tetralogy of Fallot: A Systematic Review and Meta-analysis	24
Invasive Hemodynamic Staging Classification of Cardiac Damage in Patients With Aortic Stenosis Undergoing Valve Replacement	24

Right Ventricular Longitudinal Strain Predicts Survival in Patients With Functional Tricuspid Regurgitation	23
Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management	23
Evaluation of Machine Learning Algorithms for Predicting Readmission After Acute Myocardial Infarction Using Routinely Collected Clinical Data	23
Generative Adversarial Networks in Cardiology	23
The Renin-Angiotensin System in Hypertension, a Constantly Renewing Classic: Focus on the Angiotensin AT2-Receptor	22
Cardiovascular Autonomic Disturbances in Heart Failure With Preserved Ejection Fraction	22
Recent Trends in Hospitalizations for Cardiovascular Disease, Stroke, and Vascular Cognitive Impairment in Canada	22
A Deep Learning–Enabled Electrocardiogram Model for the Identification of a Rare Inherited Arrhythmia: Brugada Syndrome	22
Advancing Digital Health Interventions as a Clinically Applied Science for Blood Pressure Reduction: A Systematic Review and Meta-analysis	22
Emulating a Randomised Controlled Trial With Observational Data: An Introduction to the Target Trial Framework	21
Prevalence and Assessment of Sleep-Disordered Breathing in Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis	21
A Deep-Learning Algorithm-Enhanced System Integrating Electrocardiograms and Chest X-rays for Diagnosing Aortic Dissection	21
Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients: Incidence and Predictors of 2-Year Good Outcome	21
First Documentation of Persistent SARS-Cov-2 Infection Presenting With Late Acute Severe Myocarditis	21
Cardiorespiratory Fitness Is an Independent Predictor of Cardiovascular Morbidity and Mortality and Improves Accuracy of Prediction Models	21
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults	20
Ventricular Tachycardia Burden and Mortality: Association or Causality?	20
The Introduction of Direct Oral Anticoagulants Has Not Resolved Treatment Gaps for Frail Patients With Nonvalvular Atrial Fibrillation	20
Objective Hemodynamic Cardiovascular Autonomic Abnormalities in Post-Acute Sequelae of COVID-19	20
Percutaneous Coronary Intervention Techniques for Bifurcation Disease: Network Meta-analysis Reveals Superiority of Double-Kissing Crush	20
Post COVID-19 Acute Myocardial Infarction Rebound	20
Management and Outcome of Patients Admitted With Tricuspid Regurgitation in France	19
Left Bundle Branch Pacing Guided by Continuous Pacing Technique That Can Monitor Electrocardiograms and Electrograms in Real Time: A Technical Report	19
Patient and Family Engagement in Care in the Cardiac Intensive Care Unit	19
Connections Between Air Pollution, Climate Change, and Cardiovascular Health	19
Optimizing Access to Heart Failure Care in Canada During the COVID-19 Pandemic	19
Cardiac Rehabilitation Programs for Chronic Heart Disease: A Bayesian Network Meta-analysis	19
Fetal Brain Development in Congenital Heart Disease	19
Inequity in Access to Transcatheter Aortic Valve Replacement: A Pan-Canadian Evaluation of Wait-Times	18
Physical Activity Is Associated With Better Vascular Function in Children and Adolescents With Congenital Heart Disease	18
Cooperation Between Hypoxia-Inducible Factor 1α and Activating Transcription Factor 4 in Sleep Apnea–Mediated Myocardial Injury	18
Colchicine Use and Incident Coronary Artery Disease in Male Patients With Gout	18
Complex Evolution of Epidemiology of Vascular Diseases, Including Increased Disease Burden: From 2000 to 2015	18
The Unique Clinical Phenotype and Exercise Adaptation of Fontan Patients With Normal Exercise Capacity	18
Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure	18
“What Is the Right Decision for Me?” Integrating Patient Perspectives Through Shared Decision-Making for Valvular Heart Disease Therapy	18
Artificial Intelligence-Powered Blockchains for Cardiovascular Medicine	18
Biologic Agents Reduce Cardiovascular Events in Rheumatoid Arthritis Not Responsive to Tumour Necrosis Factor Inhibitors: A National Cohort Study	18
Sex and Gender Bias as a Mechanistic Determinant of Cardiovascular Disease Outcomes	17
Hemodynamic Collapse After Influenza Vaccination: A Vaccine-Induced Fulminant Myocarditis?	17
Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team	17
Assessing Cardiac Risk in Pregnant Women With Heart Disease: How Risk Scores Are Created and Their Role in Clinical Practice	17
Deep Learning for Detection of Elevated Pulmonary Artery Wedge Pressure Using Standard Chest X-Ray	17
Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of the 2021 Canadian Cardiovascular Society Lipid Guidelines	17
Ramping Up the Delivery of Cardiac Surgery During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons	17
The Use of Decision Modelling to Inform Timely Policy Decisions on Cardiac Resource Capacity During the COVID-19 Pandemic	17
Sudden Cardiac Death in Diabetes and Obesity: Mechanisms and Therapeutic Strategies	17
Impact of a 22q11.2 Microdeletion on Adult All-Cause Mortality in Tetralogy of Fallot Patients	17
A Primer on the Present State and Future Prospects for Machine Learning and Artificial Intelligence Applications in Cardiology	16
The Associations of Shift Work, Sleep Quality, and Incidence of Hypertension in Ontario Adults: A Population-Based Study	16
Noninvasive Microvascular Indices Reveal Peripheral Vascular Abnormalities in Patients With Suspected Coronary Microvascular Dysfunction	16
Safety and Efficacy of Intracoronary Thrombolysis as Adjunctive Therapy to Primary PCI in STEMI: A Systematic Review and Meta-analysis	16
Sex, Gender, and Cardiovascular Health in Canadian and Austrian Populations	16
Pediatric Dyslipidemia—Beyond Familial Hypercholesterolemia	16
Women-Focused Cardiovascular Rehabilitation: An International Council of Cardiovascular Prevention and Rehabilitation Clinical Practice Guideline	16
Use of Actigraphy (Wearable Digital Sensors to Monitor Activity) in Heart Failure Randomized Clinical Trials: A Scoping Review	16
Association Between Hospital Cardiac Catheter Laboratory Status, Use of an Invasive Strategy, and Outcomes After NSTEMI	16
Circulating miRNAs Related to Long-term Adverse Cardiovascular Events in STEMI Patients: A Nested Case-Control Study	16
The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice Update	16
Gut Microbiota Dysbiosis Induced by a High-Fat Diet Increases Susceptibility to Atrial Fibrillation	15
Clinical Significance of Circulating Cardiomyocyte-Specific Cell-Free DNA in Patients With Heart Failure: A Proof-of-Concept Study	15
Clinical and Economic Outcomes Associated With Remote Monitoring for Cardiac Implantable Electronic Devices: A Population-Based Analysis	15
Cardiovascular Risk Factors and Perioperative Myocardial Infarction After Noncardiac Surgery	15
Prognostic Value of Handgrip Strength in Older Adults Undergoing Cardiac Surgery	15
Evidence-Based Management of Acute Heart Failure	15
Drugs of Misuse: Focus on Vascular Dysfunction	15
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial	15
Rapid Scholarly Dissemination and Cardiovascular Community Engagement to Combat the Infodemic of the COVID-19 Pandemic	15
Role of Coexisting ECG Anomalies in the Accuracy of Smartwatch ECG Detection of Atrial Fibrillation	14
Catheter Ablation of Low-Voltage Areas for Persistent Atrial Fibrillation: Procedural Outcomes Using High-Density Voltage Mapping	14
Determinants and Prognostic Implications of Hepatorenal Dysfunction in Adults With Congenital Heart Disease	14
Recent Insights Into Mechanisms and Clinical Approaches to Electrical Storm	14
COVID-19—Where Have All the STEMIs Gone?	14
External Validation of a Risk Prediction Model for Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy	14
COVID-19 Vaccination Prioritization on the Basis of Cardiovascular Risk Factors and Number Needed to Vaccinate to Prevent Death	14
Unique Challenges of Randomised Controlled Trials in Pediatric Cardiology	14
Exercise Training for People Living With Fontan Circulation: An Underutilized Intervention	14
Acute Vascular Benefits of Finnish Sauna Bathing in Patients With Stable Coronary Artery Disease	14
Artificial Intelligence in Cardiovascular Imaging: “Unexplainable” Legal and Ethical Challenges?	14
A Novel Risk Stratification Score for Sudden Cardiac Death Prediction in Middle-Aged, Nonischemic Dilated Cardiomyopathy Patients: The ESTIMATED Score	14

Patient-Reported Outcomes in Cardiovascular Trials	14
Pulmonary Vein Stenosis After Atrial Fibrillation Ablation: Insights From the ADVICE Trial	14
Sex-Specific Determinants of Coronary Artery Disease and Atherosclerotic Risk Factors: Estrogen and Beyond	14
Periprocedural Outcomes of Fluoroscopy-Guided Patent Foramen Ovale Closure With Selective Use of Intracardiac Echocardiography	13
Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve Replacement	13
Underutilization of Perioperative Screening for Cardiovascular Events After Noncardiac Surgery in Alberta	13
Syncope in Patients With Severe Aortic Stenosis: More Than Just an Obstruction Issue	13
Life-Course Implications of Pediatric Risk Factors for Cardiovascular Disease	13
A Province-Wide Analysis of the Epidemiology of Thoracic Aortic Disease: Incidence Is Increasing in a Sex-Specific Way	13
Recording an ECG With a Smartwatch in Newborns and Young Children: Feasibility and Perspectives	13
Interleukin-9 Aggravates Isoproterenol-Induced Heart Failure by Activating Signal Transducer and Activator of Transcription 3 Signalling	13
Epidemiology of Resistant Hypertension in Canada	13
Infertility, Infertility Treatment, and Cardiovascular Disease: An Overview	13
Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome	13
Early Mobilization in People With Acute Cardiovascular Disease	13
Accelerated Biological Aging Secondary to Cardiometabolic Risk Factors Is a Predictor of Cardiovascular Mortality: A Systematic Review and Meta-analysis	13
Plastic Bronchitis and Protein-Losing Enteropathy in the Fontan Patient: Evolving Understanding and Emerging Therapies	12
The Utility of Handheld Cardiac and Lung Ultrasound in Predicting Outcomes of Hospitalised Patients With COVID-19	12
Heart Transplant Indications, Considerations, and Outcomes in Fontan Patients: Age-Related Nuances, Transplant Listing, and Disease-Specific Indications	12
The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-analysis	12
A Systematic Review of Total Endovascular Aortic Arch Repair: A Promising Technology	12
Sex Differences in the Immune System in Relation to Hypertension and Vascular Disease	12
FIB-4 Predicts MACE and Cardiovascular Mortality in Patients With Nonalcoholic Fatty Liver Disease	12
The Exposome and Cardiovascular Health	12
Short- and Long-term Outcomes in Dialysis Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis	12
Digital Health Approaches for the Assessment and Optimisation of Hypertension Care Provision	12
Cardiovascular Care Delivery During the Second Wave of COVID-19 in Canada	12
A Continuous Pacing and Recording Technique for Differentiating Left Bundle Branch Pacing From Left Ventricular Septal Pacing: Electrophysiologic Evidence From an Intrapatient-Controlled Study	12
Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership	12
Quadriceps Strength and Mortality in Older Patients With Heart Failure	12
Health Technology Assessment for Cardiovascular Digital Health Technologies and Artificial Intelligence: Why Is It Different?	12
One-Year Risk of Myocarditis After COVID-19 Infection: A Systematic Review and Meta-analysis	12
One-Year Prospective Follow-up of Women With INOCA and MINOCA at a Canadian Women’s Heart Centre	12
Safety and Feasibility of Same-Day Discharge After Left Atrial Appendage Closure	12
Identification and Evaluation of Controlled Trials in Pediatric Cardiology: Crowdsourced Scoping Review and Creation of Accessible Searchable Database	12
Transfusion Thresholds for Adult Respiratory Extracorporeal Life Support: An Expert Consensus Document	12
Post-Discharge Cardiac Care in the Era of Coronavirus 2019: How Should We Prepare?	12
2021 Update on Safety of Magnetic Resonance Imaging: Joint Statement From Canadian Cardiovascular Society/Canadian Society for Cardiovascular Magnetic Resonance/Canadian Heart Rhythm Society	11
How Diabetes and Heart Failure Modulate Each Other and Condition Management	11
miR-532-3p-CSF2RA Axis as a Key Regulator of Vulnerable Atherosclerotic Plaque Formation	11
The Role of Machine Learning in Cardiovascular Pathology	11
Obese but Fit: The Benefits of Fitness on Cognition in Obese Older Adults	11
Clinical Outcomes After Percutaneous Patent Ductus Arteriosus Closure in Adults	11
Association Between Plasma Trimethylamine N-oxide and Neoatherosclerosis in Patients With Very Late Stent Thrombosis	11
Double-Kissing Nanocrush for Bifurcation Lesions: Development, Bioengineering, Fluid Dynamics, and Initial Clinical Testing	11
A Modern Integration of Palliative Care Into the Management of Heart Failure	11
Diagnostic Cardiovascular Magnetic Resonance Imaging Criteria in Noncompaction Cardiomyopathy and the Yield of Genetic Testing	11
Biventricular Thrombi Associated With Myocardial Infarction in a Patient With COVID-19	11
Secondary Preventative Care for Patients After Spontaneous Coronary Artery Dissection: A Qualitative Analysis of Health Care Providers’ Perspectives	11
The Rationale, Indications, Safety, and Use of Statins in the Pediatric Population	11
Deep Learning Algorithm Predicts Angiographic Coronary Artery Disease in Stable Patients Using Only a Standard 12-Lead Electrocardiogram	11
Is Occult Genetic Substrate the Missing Link Between Arrhythmic Mitral Annular Disjunction Syndrome and Sudden Cardiac Death?	11
IL-18 Promotes Erythrophagocytosis and Erythrocyte Degradation by M1 Macrophages in a Calcific Microenvironment	11
Cardiovascular Risk Factors in Patients With Congenital Heart Disease	11
HEARTBiT: A Transcriptomic Signature for Excluding Acute Cellular Rejection in Adult Heart Allograft Patients	11
Caution When Using High-Sensitivity Cardiac Troponin I Assay to Rule Out Acute Ischemia: When the Delta to Rule In Is Within Analytical Variation	11
Shared Decision Making and the Cardiovascular Care of Athletes: Is It Time to Get Back in the Game?	11
Mechanisms and Clinical Manifestations of Cognitive Decline in Atrial Fibrillation Patients: Potential Implications for Preventing Dementia	11
Cardiovascular Deaths in Pregnancy: Growing Concerns and Preventive Strategies	11
Patient Preferences and Decisional Needs When Choosing a Treatment Approach for Pregnancy Hypertension: A Stated Preference Study	11
An Approach to Investigating Discordant High-Sensitivity Cardiac Troponin I Results	11
Direct-Acting Oral Anticoagulant Choice for Stroke Prevention in Obese Patients With Atrial Fibrillation	11
Biomechanical Modeling to Inform Pulmonary Valve Replacement in Tetralogy of Fallot Patients After Complete Repair	11
Outcomes in Young Adults With Tetralogy of Fallot and Pulmonary Annular Preserving or Transannular Patch Repairs	10
Effectiveness of Coronary Sinus Reducer for Treatment of Refractory Angina: A Meta-analysis	10
Women’s Cardiac Rehabilitation Barriers: Results of the International Council of Cardiovascular Prevention and Rehabilitation’s First Global Assessment	10
Diet and Nutrition in Peripheral Artery Disease: A Systematic Review	10
Androgens and Androgen Receptors as Determinants of Vascular Sex Differences Across the Lifespan	10
Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children	10
Optimising Women’s Cardiovascular Health After Hypertensive Disorders of Pregnancy: A Translational Approach to Cardiovascular Disease Prevention	10
Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial	10
Neuroprognostication in the Post Cardiac Arrest Patient: A Canadian Cardiovascular Society Position Statement	10
The Multiple Effects of SGLT2 Inhibitors Suggest Potential Benefit in COVID-19 Patients	10
RBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy	10
Characteristics and Prognosis of Patients With Left-Sided Native Bivalvular Infective Endocarditis	10
Temporal Trends in Hospitalization for Lower Extremity Peripheral Artery Disease in Ontario: The Importance of Diabetes	10
The Association of Socioeconomic Factors With Percutaneous Coronary Intervention Outcomes	10
Recategorization of Non-Aspirin Nonsteroidal Anti-inflammatory Drugs According to Clinical Relevance: Abandoning the Traditional NSAID Terminology	10
Determinants of Cardiorespiratory Fitness After Bariatric Surgery: Insights From a Randomised Controlled Trial of a Supervised Training Program	10
Characteristics and Outcomes of Coronary Artery Involvement in Polyarteritis Nodosa	9
Catastrophic Cardiac Events During Transcatheter Aortic Valve Replacement	9
Cardiovascular Risk and Cardiovascular Health Behaviours in the Transition From Childhood to Adulthood	9
CUSP OVERLAP METHOD FOR SELF-EXPANDING TRANSCATHETER AORTIC VALVE REPLACEMENT	9
Bioprosthetic Valve Thrombosis and Obstruction Secondary to COVID-19	9
Hepatic and Renal Consequences of Single-Ventricle Physiology Palliated With the Fontan Operation	9
Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease	9
Predictors of Cumulative Health Care Costs Associated With Transcatheter Aortic Valve Replacement in Severe Aortic Stenosis	9
Sex and Gender and Allostatic Mechanisms of Cardiovascular Risk and Disease	9
Newer Methods for Ventricular Tachycardia Ablation and When to Use Them	9
Differential Roles of Life-Course Cumulative Burden of Cardiovascular Risk Factors in Arterial Stiffness and Thickness	9
Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial	9
Field Implementation of Remote Ischemic Conditioning in ST-Segment–Elevation Myocardial Infarction: The FIRST Study	9
Predicting Incident Heart Failure in Women With Machine Learning: The Women’s Health Initiative Cohort	9
Drugs for Prevention and Treatment of Aortic Stenosis: How Close Are We?	9
Responding to Cardiac Arrest in the Community in the Digital Age	9